- Home
- RAYA vs KTTA Comparison
RAYA vs KTTA Comparison
Compare RAYA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- KTTA
- Stock Information
- Founded
- RAYA 2019
- KTTA 2020
- Country
- RAYA China
- KTTA United States
- Employees
- RAYA N/A
- KTTA N/A
- Industry
- RAYA Metal Fabrications
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- KTTA Health Care
- Exchange
- RAYA Nasdaq
- KTTA Nasdaq
- Market Cap
- RAYA 6.1M
- KTTA 5.5M
- IPO Year
- RAYA 2022
- KTTA 2021
- Fundamental
- Price
- RAYA $5.73
- KTTA N/A
- Analyst Decision
- RAYA
- KTTA
- Analyst Count
- RAYA 0
- KTTA 0
- Target Price
- RAYA N/A
- KTTA N/A
- AVG Volume (30 Days)
- RAYA 378.3K
- KTTA 95.5K
- Earning Date
- RAYA 01-01-0001
- KTTA 11-12-2025
- Dividend Yield
- RAYA N/A
- KTTA N/A
- EPS Growth
- RAYA N/A
- KTTA N/A
- EPS
- RAYA N/A
- KTTA N/A
- Revenue
- RAYA $30,300,360.00
- KTTA N/A
- Revenue This Year
- RAYA $20.95
- KTTA N/A
- Revenue Next Year
- RAYA N/A
- KTTA N/A
- P/E Ratio
- RAYA N/A
- KTTA N/A
- Revenue Growth
- RAYA 49.10
- KTTA N/A
- 52 Week Low
- RAYA $3.65
- KTTA $0.65
- 52 Week High
- RAYA $737.00
- KTTA $5.06
- Technical
- Relative Strength Index (RSI)
- RAYA 64.23
- KTTA N/A
- Support Level
- RAYA $3.65
- KTTA N/A
- Resistance Level
- RAYA $5.80
- KTTA N/A
- Average True Range (ATR)
- RAYA 0.71
- KTTA 0.00
- MACD
- RAYA 0.39
- KTTA 0.00
- Stochastic Oscillator
- RAYA 50.16
- KTTA 0.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).